Transgenic mice having human CETP genes are useful models for the action of niacin in humans. Such animals exhibit an increase in HDL-C and the HDL-C/non-HDL-C ratio and a decrease in non-HDL-C when they are treated with niacin. The changes in HDL-C and non-HDL-C appear to be dose-dependent.